Since circulating FGF21 has a short half-life [113] and is elevated in HF, likely due to FGF21 resistance as a result of impaired FGF21 signalling, soluble forms of FGF21 receptor complex components could be a more stable HF biomarker than FGF21 itself. The gene discussed is FGF21; the disease is hydrops fetalis.